154 related articles for article (PubMed ID: 29343608)
1. Direct Quantification of Cytochromes P450 and Drug Transporters-A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture Lysates.
Weiß F; Hammer HS; Klein K; Planatscher H; Zanger UM; Norén A; Wegler C; Artursson P; Joos TO; Poetz O
Drug Metab Dispos; 2018 Apr; 46(4):387-396. PubMed ID: 29343608
[TBL] [Abstract][Full Text] [Related]
2. A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes.
Wang MZ; Wu JQ; Dennison JB; Bridges AS; Hall SD; Kornbluth S; Tidwell RR; Smith PC; Voyksner RD; Paine MF; Hall JE
Proteomics; 2008 Oct; 8(20):4186-96. PubMed ID: 18792928
[TBL] [Abstract][Full Text] [Related]
3. Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.
Khatri R; Fallon JK; Rementer RJB; Kulick NT; Lee CR; Smith PC
J Pharmacol Toxicol Methods; 2019; 98():106590. PubMed ID: 31158457
[TBL] [Abstract][Full Text] [Related]
4. Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes.
Schaefer O; Ohtsuki S; Kawakami H; Inoue T; Liehner S; Saito A; Sakamoto A; Ishiguro N; Matsumaru T; Terasaki T; Ebner T
Drug Metab Dispos; 2012 Jan; 40(1):93-103. PubMed ID: 21979928
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Proteomic Quantification Approaches for Hepatic Drug Transporters: Multiplexed Global Quantitation Correlates with Targeted Proteomic Quantitation.
Vildhede A; Nguyen C; Erickson BK; Kunz RC; Jones R; Kimoto E; Bourbonais F; Rodrigues AD; Varma MVS
Drug Metab Dispos; 2018 May; 46(5):692-696. PubMed ID: 29439128
[TBL] [Abstract][Full Text] [Related]
6. A novel mass spectrometry method for the absolute quantification of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in the human liver.
Lv Y; Zhang H; Wang G; Xia C; Gao F; Zhang Y; Qiao H; Xie Y; Qin W; Qian X
Anal Bioanal Chem; 2020 Mar; 412(8):1729-1740. PubMed ID: 32030490
[TBL] [Abstract][Full Text] [Related]
7. Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes.
Achour B; Al Feteisi H; Lanucara F; Rostami-Hodjegan A; Barber J
Drug Metab Dispos; 2017 Jun; 45(6):666-675. PubMed ID: 28373266
[TBL] [Abstract][Full Text] [Related]
8. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
[TBL] [Abstract][Full Text] [Related]
9. Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes.
Wegler C; Gaugaz FZ; Andersson TB; Wiśniewski JR; Busch D; Gröer C; Oswald S; Norén A; Weiss F; Hammer HS; Joos TO; Poetz O; Achour B; Rostami-Hodjegan A; van de Steeg E; Wortelboer HM; Artursson P
Mol Pharm; 2017 Sep; 14(9):3142-3151. PubMed ID: 28767254
[TBL] [Abstract][Full Text] [Related]
10. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
[TBL] [Abstract][Full Text] [Related]
11. Selective and sensitive quantification of the cytochrome P450 3A4 protein in human liver homogenates through multiple reaction monitoring mass spectrometry.
Cieślak A; Kelly I; Trottier J; Verreault M; Wunsch E; Milkiewicz P; Poirier G; Droit A; Barbier O
Proteomics; 2016 Nov; 16(21):2827-2837. PubMed ID: 27634100
[TBL] [Abstract][Full Text] [Related]
12. Application of slicing of one-dimensional gels with subsequent slice-by-slice mass spectrometry for the proteomic profiling of human liver cytochromes P450.
Lisitsa AV; Petushkova NA; Thiele H; Moshkovskii SA; Zgoda VG; Karuzina II; Chernobrovkin AL; Skipenko OG; Archakov AI
J Proteome Res; 2010 Jan; 9(1):95-103. PubMed ID: 19722723
[TBL] [Abstract][Full Text] [Related]
13. Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics.
Couto N; Al-Majdoub ZM; Achour B; Wright PC; Rostami-Hodjegan A; Barber J
Mol Pharm; 2019 Feb; 16(2):632-647. PubMed ID: 30608694
[TBL] [Abstract][Full Text] [Related]
14. Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques.
Al Feteisi H; Achour B; Rostami-Hodjegan A; Barber J
Expert Opin Drug Metab Toxicol; 2015; 11(9):1357-69. PubMed ID: 26108733
[TBL] [Abstract][Full Text] [Related]
15. Reliability and robustness of simultaneous absolute quantification of drug transporters, cytochrome P450 enzymes, and Udp-glucuronosyltransferases in human liver tissue by multiplexed MRM/selected reaction monitoring mode tandem mass spectrometry with nano-liquid chromatography.
Sakamoto A; Matsumaru T; Ishiguro N; Schaefer O; Ohtsuki S; Inoue T; Kawakami H; Terasaki T
J Pharm Sci; 2011 Sep; 100(9):4037-43. PubMed ID: 21544820
[TBL] [Abstract][Full Text] [Related]
16. Quantitative shot-gun proteomics and MS-based activity assay for revealing gender differences in enzyme contents for rat liver microsome.
Huang HJ; Tsai ML; Chen YW; Chen SH
J Proteomics; 2011 Nov; 74(12):2734-44. PubMed ID: 21300189
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry-based proteomic analysis of human liver cytochrome(s) P450.
Shrivas K; Mindaye ST; Getie-Kebtie M; Alterman MA
Toxicol Appl Pharmacol; 2013 Feb; 267(1):125-36. PubMed ID: 23274569
[TBL] [Abstract][Full Text] [Related]
18. Quantitative protein determination for CYP induction via LC-MS/MS.
Williamson BL; Purkayastha S; Hunter CL; Nuwaysir L; Hill J; Easterwood L; Hill J
Proteomics; 2011 Jan; 11(1):33-41. PubMed ID: 21182192
[TBL] [Abstract][Full Text] [Related]
19. Targeted LC-MS/MS Proteomics-Based Strategy To Characterize in Vitro Models Used in Drug Metabolism and Transport Studies.
Xu M; Saxena N; Vrana M; Zhang H; Kumar V; Billington S; Khojasteh C; Heyward S; Unadkat JD; Prasad B
Anal Chem; 2018 Oct; 90(20):11873-11882. PubMed ID: 30204418
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of cytochrome P450 isoforms in human liver microsomes by the combination of proteomics and chemical probe-based assay.
Liu X; Hu L; Ge G; Yang B; Ning J; Sun S; Yang L; Pors K; Gu J
Proteomics; 2014 Aug; 14(16):1943-51. PubMed ID: 24920405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
